Tag Archives: highaltitude

Acclimation, Altitude Science, Diabetes, Exposure, Genetics, Health, High Altitude

Living High and Testing Higher: Can Living at High Altitudes Skew Diagnostic Diabetes Tests? 

Leave a comment

by Hailey Garin PA-S

Diabetes is very prevalent in our society, with around 11% of the population in the United States diagnosed with this disease2. A key diagnostic test used in healthcare is the hemoglobin A1c (HbA1c) blood test. This blood test measures an individual’s average blood sugar over a 3-month period. A value of less than 5.7% is normal, 5.7%-6.4% is pre-diabetic range, and 6.5% and greater is a diagnosis of diabetes1. There are other blood tests that are used in the diagnoses of diabetes including fasting plasma glucose (FPG) and 2-hour postprandial glucose (2-h PG) testing. FPG testing measures blood sugar levels after 8 or more hours of fasting. A FPG value of 126 mg/dl or greater is diagnostic of diabetes. The 2-h PG test is a blood sugar reading 2 hours after eating a meal. A 2-h PG value of 200 mg/dl or higher is diagnostic of diabetes3. Currently the HbA1c blood test is the most used to diagnose diabetes, and many individuals around the world are diagnosed and placed on medications based off HbA1c results alone.

But is this appropriate for individuals living at altitude? 

A groundbreaking study completed in mainland China has begun to answer this question for us. Altitudes and Hemoglobin A1c Values: An Analysis Based on Two Nationwide Cross-sectional Studies by Zheng et al was published in 2024. In this study, 95,000 adults were examined by comparing HbA1c, fasting blood glucose, and 2-hour postprandial (after a meal) glucose levels between individuals living above and below 2,500 meters (8,200 feet)4. 

A key finding of this study was that individuals living above 2,500 meters had higher HbA1c levels but the same FPG and 2-h PG results as individuals below 2,500 meters4. The individuals at altitude may have HbA1c levels that are falsely elevated. This inaccuracy can lead to an inappropriate diagnosis of diabetes in individuals living at altitude. The researchers explained that oxygen levels at higher elevations are lower, and the body reacts to these low levels by increasing levels of red blood cells and the lifespan of red blood cells. When lifespan is increased, the hemoglobin is exposed to glucose in our blood stream for longer, eliciting a higher HbA1c result despite normal blood sugar levels4. 

Another study by Bazo-Alvarez et. al in 2017 sought to evaluate the relationship between HbA1c and FPG among individuals at sea level compared to those at high altitude.

The study analyzed data from 3613 Peruvian adults without diagnosed diabetes from both sea level and high altitude (>3000m). The mean values for hemoglobin, HbA1c, and FPG differed significantly between these populations. The correlation between HbA1c and FPG was quadratic at sea level but linear at high altitude, suggesting different glucose metabolism patterns. Additionally, for an HbA1c value of 48 mmol/mol (6.5%), corresponding mean FPG values were significantly different: 6.6 mmol/l at sea level versus 14.8 mmol/l at high altitude.

These studies show that one-size-fits all screening for diabetes may not work for everyone, especially those living at altitude. Ebert Family Clinic, at 2743m (9000 ft) in the Colorado Rocky Mountains, has been researching the effects of altitude on many aspects of health including examining HbA1c levels in our residents and thus far we have seen elevated HbA1c levels in our otherwise healthy, “thin”, and active patients despite implementing appropriate lifestyle interventions to lower blood sugar. This can lead to unnecessary health anxiety that we hope to avoid by determining if HbA1c will continue to be an appropriate diagnostic tool with our residents living well above 2,500 meters.

References

1. Centers for Disease Control and Prevention. (n.d.-a). A1C test for diabetes and Prediabetes. Centers for Disease Control and Prevention. https://www.cdc.gov/diabetes/diabetes-testing/prediabetes-a1c-test.html 

2. Centers for Disease Control and Prevention. (n.d.-b). National Diabetes Statistics Report. Centers for Disease Control and Prevention. https://www.cdc.gov/diabetes/php/data-research/index.html 

3. U.S. Department of Health and Human Services. (n.d.). Diabetes tests & diagnosis – NIDDK. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/diabetes/overview/tests-diagnosis 

4. Zheng, R., Xu, Y., Li, M., Wang, L., Lu, J., Wang, T., Xu, M., Zhao, Z., Zheng, J., Dai, M., Zhang, D., Chen, Y., Wang, S., Lin, H., Wang, W., Ning, G., & Bi, Y. (2024). Altitudes and hemoglobin A1C values: An analysis based on two nationwide cross-sectional studies. Diabetes Care, 47(2). https://doi.org/10.2337/dc23-1549 

Acclimation, Altitude Science, Anesthesia, Health, High Altitude, Medicine, Technology

Anesthesia and Altitude

Leave a comment

by Megan Wilson, NP-S

One of the last things anybody wants to go through is a surgical procedure, especially if you happen to be in the mountains on vacation. Unfortunately, life happens, and whether you’re a visitor to high-altitude or a permanent resident, there is a chance you may need surgical care. 

Anesthesia is a requirement for surgical procedures and there are varying levels of anesthetic available. General anesthesia, often referred to as “going off to sleep”, is where you are completely unconscious and anesthetic gases and medications keep you sedated while a machine breathes for you during your procedure. Monitored anesthesia care (MAC), also known as conscious sedation, is when the anesthesiologist keeps you comfortable with meds, but you are still able to breathe on your own. Medications given for surgery affect your ability to breathe, which is why your vital signs (oxygen levels, blood pressure, heart rate) are monitored through a machine by a doctor. 

How is this different at high altitude?

When you head to higher elevations, barometric pressure decreases and causes partial pressure of oxygen to decrease – this makes oxygen harder to effectively get into your lungs and causes hypoxemia/low oxygen levels (Leissner & Mahmood, 2009). This leads to a condition commonly known as altitude sickness, causing headaches and trouble breathing, and in more serious cases, it can also lead to high altitude pulmonary edema (HAPE) and high altitude cerebral edema (HACE). Much like oxygen, anesthetic gases are also affected by barometric pressures, impacting the effectiveness of inhaled anesthetics (Bebic et al., 2021). Additionally, equipment is affected by high altitude – meters on anesthesia machines that monitor gas/oxygen levels tend to under-read at higher elevations (Bebic et al., 2021; Leissner & Mahmood, 2009). Pulse oximetry, which measures your overall oxygen saturation (the percentage of oxygen in your blood) also has limited accuracy at high altitude (Bebic et al., 2021). Providers who practice at higher elevations should be aware of these nuances and treat accordingly. The most important treatment we have to help with the effects of partial pressure at high altitude is supplemental oxygen (Leissner & Mahmood, 2009).  

Unfortunately, there is limited research on the effects of high altitude and anesthesia, and even less on the effects of anesthetic drugs at high altitude vs. sea level (Bebic et al., 2021). With current published data, it is clear that surgical risks increase with elevation. Whether it’s the potential for equipment to malfunction, or novice providers new to high-altitude unaware of the subtleties in treatment, it is critical to be mindful of compromised respiratory status at elevation when considering which anesthetic agents to use for surgery. 

References

Bebic, Z., Brooks Peterson, M., & Polaner, D. M. (2021). Respiratory physiology at high altitude and considerations for pediatric patients. Pediatric Anesthesia, 32(2), 118-125.

https://doi.org/10.1111/pan.14380

Leissner, K. B., & Mahmood, F. U. (2009). Physiology and pathophysiology at high altitude:

Considerations for the anesthesiologist. Journal of Anesthesia, 23(4), 543-553.

https://doi.org/10.1007/s00540-009-0787-7

Acclimation, Altitude Science, Athletic Training, Health, High Altitude, High Altitude Training & Fitness

KYRGYZSTAN VS SUMMIT COUNTY, COLORADO: EXERCISE AT ALTITUDE

Leave a comment

How does the low oxygen environment at altitude affect our ability to exercise?  What is the risk for developing harmful changes in the heart and lungs? Does sleep apnea contribute to these risks? Can supplemental oxygen reverse or reduce these risks and increase our exercise ability at altitude?

An audience of conference participants sit observing a slide in a presentation reading "Cardiac function and PH in 97 Kyrgyz Highlander and 76 Lowlander (50% women).

These important questions have been studied by an international research team conducting tests on residents of the Tien Shan mountain range in Kyrgyzstan, 2500-3500 m (8,200 to 11,482 feet). Dr. Silvia Ulrich presented some of their findings at the Hypoxia 2025 conference in Lake Louise in the Canadian Rocky Mountains this past winter. Using an exercise bike they measured ECG, pulmonary gas exchange and oxygen saturation in healthy highlanders. Participants’ average age was 48 years, 46 % were women, and their average oxygen saturation (SpO2) at rest was 88%. Normal occupations include nomadic herdsmen, hunters and soldiers who usually travel by car or horse, with no prior experience cycling or running. An echocardiogram was performed to assess pulmonary artery pressures (PAP) and right heart function.

Arterial blood gas analysis at baseline showed a normal pH, low oxygen, mildly decreased carbon dioxide and bicarbonate, and higher hemoglobin concentrations. Bicarbonate values were 22-26 moles/L. In Summit county, in the Rocky Mountains of Colorado, with residents living between 2500 to 3300 m bicarbonate values are 17-20 moles/L.

Results showed their peak oxygen uptake, and peak work rate was reduced by one quarter compared to predicted values for lowlanders. Oxygen saturation decreased during exercise. “Exercise limitation was related to an exercise -induced worsening of hypoxemia, high ventilation equivalents for oxygen uptake and carbon dioxide output, a reduced external work efficiency and a lower peak heart rate than predicted for age.” (1) In other words, they had to breathe harder to maintain their oxygen and carbon dioxide at normal values and use more effort for the same musculoskeletal output. Their heart rate did not increase as much as a person from lower altitude doing the same work.

There is little research on exercise capacity in long-term residents at altitude.  Most studies focus on athletes or comparing healthy acclimatized men to recent arrivals. The hypoxic environment is a known risk for pulmonary hypertension, which can lead to exercise intolerance and fatigue that is reversible with descent or oxygen use when diagnosed in a timely manner. Sleep apnea with the accompanying hypoxic episodes adds to this risk. Summit County residents show improvement in both systemic and pulmonary hypertension with supplemental oxygen during sleep, according to local health care providers.

Kyrgyzstan residents studied showed a strong correlation between  the incidence of sleep apnea with hypoxia (time below 90% SpO2), and abnormal pulmonary artery pressures. Echocardiograms compared 97 highlanders with 76 lowlanders who were asymptomatic. Between 6% and 35% had increased PAP depending on which definition is used. 

A slide at a conference presentation on the effect of high-dose SOT on pulmonary artery pressures and cardiac output in highlanders at risk for PH at 3250 meters.

The research team also evaluated their response to supplemental oxygen at altitude and 760m elevation using the six minute walk test. Although the test subjects reported less shortness of breath and had higher measured oxygen levels they were not able to walk further. Supplemental oxygen did reduce pulmonary artery pressures in those at risk when tested at 3,200 m.

A slide from a presentation on an experiment where oxygen levels in residents of high altitude in Kyrgyzstan are measured during a 6-minute walk.

This research was conducted by a crew of scientists who brought all the equipment with them to a basic medical clinic in a village.

Summit County cardiologist Warren Johnson was impressed by the numbers of people with elevated pressures in their lungs. “It could be as high as 30 per cent of adults,” he told local physicians. Symptoms are subtle: decreased exercise tolerance, mild shortness of breath, trouble sleeping, high red blood cell counts. Most people just think they are out of condition or aging.

A study in Spiti Valley India of residents living at 9000-13000 ft found an incidence of three per cent with PH.  Dr Johnson suspects this is a highly adapted population with centuries of mountain living.

Diagnosing this condition early with Echocardiogram can prevent serious disability.  Treatment is as simple as sleeping on oxygen. These measurements and much more are performed on a daily basis at the St. Anthony Summit Hospital, a 34-bed hospital serving five counties in Colorado, located at 2800 m. A parallel study to establish baseline normal values for the healthy population and identify the risk for pulmonary hypertension in asymptomatic mountain residents would be valuable for health care providers who are frequently asked to counsel residents on the risk of living at altitude.

References

Forrer A, Scheiwiller PM, Mademilov M, Lichtblau M, Sheraliev U, Marazhapov NH, Saxer S, Bader P, Appenzeller P, Aydaralieva S, Muratbekova A, Sooronbaev TM, Ulrich S, Bloch KE, Furian M. Exercise Performance in Central Asian Highlanders: A Cross-Sectional Study. High Alt Med Biol. 2021 Dec;22(4):386-394. doi: 10.1089/ham.2020.0211. Epub 2021 Aug 24. PMID: 34432548.

Lichtblau M, Saxer S, Furian M, Mayer L, Bader PR, Scheiwiller PM, Mademilov M, Sheraliev U, Tanner FC, Sooronbaev TM, Bloch KE, Ulrich S. Cardiac function and pulmonary hypertension in Central Asian highlanders at 3250 m. Eur Respir J. 2020 Aug 20;56(2):1902474. doi: 10.1183/13993003.02474-2019. PMID: 32430419.

Acclimation, Acetazolamide, Altitude Science, Child Growth & Development, Diamox, Doc Talk, Health, High Altitude, Medicine, Sleep at Altitude

Sharing at the Chateau: 23rd International Hypoxia Symposium in Lake Louise

Leave a comment

I attended the 23rd International Hypoxia Symposium in Lake Louise, Canada to present some of the research on altitude I’ve been conducting in Colorado. The conference has been going on since 1979, and for the past 26  years the organizers have been Robert Roach and Peter Hackett, world-renowned medical researchers from Colorado. Meeting most of the famous altitude researchers from all over the world was an inspiration.  Personal talks and sharing information were equally important to imbibing the latest knowledge about hypoxia and hemoglobin.

A slide is projected onto a screen over the heads of conference participant, depicting statistics showing infant birthweight in mammals decreasing over increasing elevations.
From Jay Storz’s presentation at the 2025 International Hypoxia Symposia in Lake Louise, Canada

Antarctic Icefish: Life Without Hemoglobin, was presented by Kristen O’Brien, expanding the concept of oxygen distribution in living beings and introducing us to varieties of fish we have never heard of. Her talk was followed by our “Mice and Men” guy, Jay Storz (and colleague Graham Scott), who along with Jon Velotta mentioned in our blogpost on the show “This Podcast Will Kill You” collect the large eared deer mice from peaks such as Blue Sky Mountain to study adaptation to hypoxia in their labs. The talk recognized for first prize was on Altitude Headaches, including a discussion of migraines, by Andrew Charles.

Every evening there was a banquet and speaker.  Astronaut Jessica Meir spent 210 days aboard the space station.  She shared a wide range of challenges such as exercising without gravity, choosing a compatible crew, getting boxes of treats from home, and effects of prolonged weightlessness on your eyes and muscles.

A slide projected onto a conference room screen before participants depicts results for six minute walks on and off oxygen.
Silvia Ulrich presented on Pulmonary Circulation of Central Asian Highlanders at the 2025 International Hypoxia Symposium at Lake Louise, Canada.

The research I would like to see duplicated in Summit County was from Kyrgyzstan, where Silvia Ulrich studied the hearts and lungs of the permanent residents at 9000 feet using the six minute walk as one of her tools.  They did not score higher when studied at sea level! She ran tests for pulmonary hypertension, which could be important here.

Of course, there was a talk on Sleep Disordered Breathing (sleep apnea) by Esther Schwarz, something we pay a great deal of attention to in our own clinic in Frisco, Colorado and have several research projects on the improvement we see with supplemental oxygen. The role of mitochondria in cellular function in hypoxia was presented by Dr. Christian Arias-Reyes, a researcher at Seattle Children’s Hospital who is originally from La Páz, Bolivia.  I met him at the Chronic Hypoxia conference in 2019 when he was a graduate student in Quebec and again in La Páz at this year’s conference. 

A line of people pose in front of a cafe with signs and plants hanging above a stone-tiled street lined with buildings
Altitude experts Dr. Zubieta Calleja, Dr. Christian Arias-Reyes, Dr. Michele Samaja and Dr. Christine Ebert-Santos with colleagues of the Hypoxia Symposia in front of a pizzeria in Coroico, Bolivia.

A deep dive into how our neurons react to hypoxia in the brain by releasing nitric oxide to dilate blood vessels and preserve circulation reenforced the counseling I do here in my clinic to parents whose children have breath holding spells or babies with dips in their oxygen on home monitors. Along with all the millions of children and adults living at 12,000 feet in Bolivia, we can witness that hypoxia does not cause brain damage. (Not to be confused with anoxia, a complete lack of oxygen.)

Lastly, Nobel prize winner and fellow pediatrician Gregg Semenza spoke on research to find a blocking compound against HIF- hypoxia inducible factor, as a cure for some cancers. Gregg’s work was described in our blog on the Nobel prize being awarded to scientists working on hypoxia. HIF deserves its own blogpost! More about cancer and hypoxia at altitude from the Chronic Hypoxia Conference in La Páz.

I was selected to give my presentation, “Colorado Kids Are Smaller” to both conferences. I have been working on this for 20 years. You can read more on our blog where it is titled “Mountain Kids Are Smaller”.  My goal is to get a unique growth chart for children under age two at altitude, to save parents and providers anxiety and money trying to get our kids to “be the same” as those at sea level.

The most useful tidbit of information came on the bus ride back to Calgary. Dr Heimo Mairbaurl, PhD shared that a quarter dose of acetazolamide was sufficient for his acute mountain sickness symptom prevention, 62 mg for a guy over 6 feet tall. Although there was a study on a new possible preventive treatment, prochlorperazine, done on Mount Blue Sky last fall, I still swear by the old drug formerly known as “Diamox”.

Acclimation, Altitude Science, Exposure, Health, High Altitude

ERUCTILE DYSFUNCTION AT ALTITUDE: Low Barometric Pressures Worsen Discomfort for Those Who Can’t Burp

Leave a comment

by Noor Pawar, PA-S


Retrograde Cricopharyngeus Dysfunction and the Impact of Altitude

Lucie Rosenthal’s journey, captured in her viral Reddit video, sheds light on a lesser-known condition: retrograde cricopharyngeus dysfunction, or “no-burp syndrome.” What makes her story particularly fascinating is the intersection of this medical condition with the effects of altitude—a factor that significantly influences our bodies and their functions.

In her video, Lucie joyfully discovers her ability to burp after a procedure that injects Botox into the upper esophageal muscle. However, her initial excitement turns into an uncontrollable experience that raises questions about the body’s mechanisms, especially in relation to altitude. As she recounts the bloating and discomfort that accompanied her condition, it echoes a broader issue faced by many individuals living in higher elevations, where changes in atmospheric pressure can exacerbate gastrointestinal symptoms.

The relationship between altitude and digestive health is an important consideration. At higher elevations, the reduced atmospheric pressure can lead to gas expansion in the stomach and intestines, intensifying feelings of bloating and discomfort. This is particularly relevant for individuals like Daryl Moody, who struggled with no-burp syndrome while also engaging in activities like skydiving. As he ascended, the altitude caused his stomach to inflate like a bag of chips, amplifying his discomfort and highlighting how altitude can complicate existing health issues.

The article emphasizes the growing awareness surrounding retrograde cricopharyngeus dysfunction, especially through online communities like the r/noburp subreddit. These platforms provide vital support for those affected, particularly in regions where altitude impacts digestive health. It’s a testament to how individuals can come together to share experiences and coping strategies, transforming personal struggles into a collective understanding of a shared condition.

The financial barriers mentioned in the article are further complicated for those living in high-altitude areas. With treatments often deemed “experimental” by insurance companies, individuals may face significant out-of-pocket expenses, particularly in regions where healthcare costs are already high.

Historically reports of individuals unable to burp date back centuries. The contemporary acknowledgment of retrograde cricopharyngeus dysfunction reflects an evolving understanding of how environmental factors, such as altitude, can play a crucial role in health. As we continue to learn more about this condition, the need for further research into the effects of altitude on digestive health becomes increasingly apparent.

In summary, Lucie Rosenthal’s story illustrates the complexities of retrograde cricopharyngeus dysfunction, particularly in relation to altitude. The interplay between physiological responses and environmental factors underscores the importance of patient advocacy and community support in addressing these issues. As we navigate our health, understanding how altitude can influence our bodies highlights the need for a comprehensive approach to medical care that considers all aspects of a patient’s environment.

Accessibility, Acclimation, Altitude Science, Athletic Training, Child Growth & Development, Exposure, Genetics, Health, High Altitude, Medicine, Postural Orthostatic Tachycardia Syndrome (POTS)

Thin Air Making You Lightheaded?

2 Comments

by Joy Plutowski, PA-S2

Feeling lightheaded after going to a high altitude is a key symptom of acute mountain sickness (AMS)—a condition caused by the reduced oxygen available in thin mountain air. AMS often comes with other symptoms like headache, nausea, and fatigue, usually starting after a recent climb to higher elevations.

But what if it’s not just AMS? For people with conditions like postural orthostatic tachycardia syndrome (POTS), which affects blood flow and heart rate, lightheadedness at altitude could be a clue to an underlying issue. While AMS happens because of low oxygen, POTS is tied to a problem with how the nervous system regulates the body. In some cases, going to altitude might even uncover undiagnosed POTS, as symptoms can become more noticeable in these conditions.

Living With POTS

Living with POTS has been a journey of adaptation, requiring constant vigilance and adjustment to manage a complex array of symptoms. Each new environment brings its own challenges, demanding a personalized approach to maintaining stability. My recent clinical rotation in Frisco, Colorado, situated at 9,000 feet above sea level, provided an invaluable opportunity to observe firsthand how altitude influences the physiology of POTS. An overnight stay in Denver for partial acclimatization helped mitigate some initial altitude-related exacerbations, but the first few days at higher elevation were marked by pronounced symptoms, including lightheadedness, tachycardia, and insomnia. Physically demanding activities, such as snowboarding, pushed my body to its limits, resulting in extreme fatigue and heightened tachycardia. Despite these challenges, I observed gradual improvement; by the second week, I had returned to my baseline—if not better than during my time in the heat of Phoenix, Arizona. Interestingly, the colder temperatures of the region seemed to offer symptomatic relief, likely through vasoconstriction that may enhance circulation. These experiences have deepened my understanding of POTS as a highly individualized condition, emphasizing the critical importance of lifestyle modifications, environmental considerations, and a patient-specific approach to management. My journey underscores how adaptability and tailored interventions can significantly improve functionality and quality of life for those navigating the complexities of this syndrome.

What is POTS?

Postural Orthostatic Tachycardia Syndrome (POTS) is a chronic condition characterized by an abnormal increase in heart rate upon standing. It is a form of dysautonomia, involving dysregulation of the autonomic nervous system, which balances the sympathetic (“fight or flight”) and parasympathetic (“rest and digest”) systems. The autonomic nervous system regulates involuntary bodily functions such as heart rate, blood pressure, and digestion. POTS primarily affects women, with symptoms often appearing in their teens or twenties. It is estimated to affect between 1 to 3 million people in the United States, though it is likely underdiagnosed due to lack of awareness. Under normal conditions, standing triggers the body to constrict blood vessels and slightly increase heart rate to counteract gravity’s effects. In POTS, this response is impaired, leading to blood pooling in the lower extremities and reduced blood flow to the brain. The exact cause of POTS is not fully understood, but it is commonly linked to viral infections, autoimmune conditions, genetic predispositions, small fiber neuropathy, impaired norepinephrine regulation, or hypovolemia (low blood volume). Notably, long-COVID, a range of long-term symptoms and conditions resulting from an acute COVID infection, is linked to POTS. Approximately 1% of patients with an acute COVID-19 infection go on to develop orthostatic intolerance (Cheshire, 2024). Studies also show that keeping up with COVID-19 vaccinations can prevent long-COVID.

The hallmark symptom of POTS is an excessive increase in heart rate of over 30 bpm quickly after standing (WP, 2024). Common symptoms include tachycardia, palpitations, dizziness, and fainting (syncope or near-syncope), brain fog, headaches, lightheadedness, and severe fatigue. Less common symptoms include nausea, bloating, abdominal discomfort, shakiness, and exercise intolerance. POTS symptoms are often worsened by factors such as dehydration, heat, prolonged standing, illness, or physical stress. Diagnosing POTS involves a tilt-table test which monitors heart rate and blood pressure during positional changes. Treatment for POTS focuses on improving symptoms and quality of life through lifestyle adjustments. Key components include hydration, increased salt intake, compression garments, graded exercise therapy, and psychological support. Medications such as Fludrocortisone or Midodrine, that both increase blood pressure, may be added if the provider deems it fit. The course of POTS varies widely; some individuals experience significant improvement with treatment, others may have persistent symptoms. Early diagnosis and a multidisciplinary approach can lead to better outcomes.

The Effect of Altitude on the Autonomic Nervous System

Altitude significantly influences the autonomic nervous system due to reduced oxygen levels and atmospheric pressure, which challenge the body’s ability to maintain homeostasis. At higher elevations, the sympathetic nervous system becomes more active, increasing heart rate and blood pressure to compensate for lower oxygen availability. This is because hypoxia alters chemoreceptor and baroreceptor function, leading to increased sympathetic excitation and decreased parasympathetic tone.

During a study at 4300 m, urine norepinephrine levels—a marker of sympathetic activity—peaked 4–6 days after altitude exposure (Mazzeo, 1998). The study compared women in different hormonal phases when exposed to high altitude. The urinary norepinephrine levels heart rates both increased over time in both follicular and luteal phases. The differences between the two were not statistically significant, showing that women experience sympathetic increase at altitude regardless of what phase of their cycle. This was done in comparison to a previous study showing the same findings in men (Mazzeo, 1998). 

A line graph indicating the rise follicular and luteal heart rates in beats per minute as days at altitude increase.
A line graph indicating increasing amounts per 24 hours of urinary norepinephrine.

Other physiological responses include increased ventilation, cardiac output, and heart rate. However, with acclimatization, heart rate and cardiac output typically return to sea-level values within 9–12 days (Hainsworth et al., 2007). Over time, improved oxygen-carrying capacity enhances tolerance to orthostatic stress. All in all, orthostatic tolerance during hypobaric hypoxia involves three mechanisms: cardiovascular control of heart rate and cardiac output, cerebrovascular responses to hypocapnic hypoxia (due to hyperventilation), and elevated sympathetic activity (Blaber et al., 2003). 

For individuals with POTS, altitude-related stresses may exacerbate symptoms. Hypoxia and reduced barometric pressure can worsen fatigue, brain fog, and dizziness by increasing the body’s effort to oxygenate tissues. Reduced oxygen delivery to the brain and tissues may intensify lightheadedness and syncope— which is already common in POTS.

Although acclimatization typically occurs within 1–2 weeks at altitude in healthy individuals, research on acclimatization in POTS patients is limited. Further studies are needed to determine whether individuals with autonomic dysfunction can adapt as effectively as those without.

Living With POTS at Altitude 

Living with POTS at altitude presents unique challenges that require careful management, as patients may find it harder to adapt to the altitude-induced changes in blood oxygenation and pressure regulation. These challenges are compounded by the existing difficulties they face in maintaining autonomic stability. The reduced oxygen levels and increased demands on the cardiovascular system can amplify POTS symptoms, making daily activities more difficult. Patients with POTS generally understand their triggers and have a protocol that was formulated with their provider. Such strategies include staying well-hydrated, using compression garments, increasing salt intake, decreasing alcohol and caffeine consumption, and avoiding sudden changes in posture. Also, gradual exposure to altitude helps the body adapt to the reduced oxygen and barometric pressure, minimizing symptom flares. For individuals with POTS visiting high-altitude environments, strict adherence to their treatment regimen, including lifestyle modifications and potentially pharmacologic interventions, is paramount for managing their condition effectively.

References

Blaber AP, Hartley T, Pretorius PJ (2003) Effect of acute exposure to 3,660 m altitude on orthostatic responses and tolerance. J Appl Physiol 95:591–601

Cheshire WP. (2024) Postural tachycardia syndrome. UpToDate. 

Hainsworth, R., Drinkhill, M. J., & Rivera-Chira, M. (2007). The autonomic nervous system at high altitude. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 17(1), 13–19

Mazzeo RS, Child A, Butterfield GE, et al. (1998) Catecholamine response during 12  days of high-altitude exposure (4,300 m) in women. J Appl Physiol 84:1151–1157

Joy Plutowski is a second-year PA student born and raised in Arizona. She completed her undergraduate degree in biology at Arizona State University and is now pursuing her master’s at Midwestern University in Glendale, AZ. Before PA school, she worked as a medical scribe for an interventional cardiologist, a field she is interested in pursuing. Currently, she has the wonderful opportunity of completing her pediatrics rotation in Frisco, CO. In her free time, Joy enjoys exploring national parks, playing video games, dancing, and most recently, snowboarding.